Which anticoagulant works by directly inhibiting thrombin?

• A. Warfarin
• B. Dabigatran
• C. Apixaban
• D. Rivaroxaban

Answer: (B)

Dabigatran is the anticoagulant that works by directly inhibiting thrombin, which is a key enzyme in the coagulation cascade responsible for converting fibrinogen to fibrin, ultimately leading to clot formation. By binding directly to thrombin, dabigatran effectively prevents the formation of a stable blood clot, making it particularly useful in managing conditions such as atrial fibrillation and venous thromboembolic events.

In contrast, warfarin functions by inhibiting vitamin K-dependent factors, which are necessary for the synthesis of several clotting factors. This approach impacts the clotting process indirectly, rather than directly targeting thrombin. The other anticoagulants mentioned, apixaban and rivaroxaban, are factor Xa inhibitors, meaning they block the activity of factor Xa in the coagulation pathway, which also leads to reduced thrombin generation but not through direct interaction with thrombin itself. Hence, dabigatran stands out as the specific agent that directly inhibits thrombin, distinguishing its mechanism of action from the others.